Infectious-disease doctors have proposed a speedier, easier approval process for drug companies developing antibiotics against untreatable illnesses.
The Infectious Diseases Society of America (IDSA) made the proposal today at a hearing of a subcommittee of the US House of Representatives Committee on Energy and Commerce. The hearing focused on reauthorization of the Prescription Drug User Fee Act, which funds the US Food and Drug Administration (FDA).
The Infectious Diseases Society of America (IDSA) made the proposal today at a hearing of a subcommittee of the US House of Representatives Committee on Energy and Commerce. The hearing focused on reauthorization of the Prescription Drug User Fee Act, which funds the US Food and Drug Administration (FDA).
